β-cryptoxanthin, though less studied, has been shown to decrease the expression of inflammatory cytokines (IL-1β, TNF-α, and IL-6) and matrix metalloproteinase 13 (MMP-13) in the primary chondrocytes of mice, leading to amelioration of osteoarthritis development [30]. Here, MMP13 is linked to osteoarthritis.